Days Inventory is also known as Days Sales of Inventory (DSI). Thoratec's Average Total Inventories for the
three
months ended in Jun. 2015 was €61.6 Mil. Thoratec's Cost of Goods Sold for the
three
months ended in Jun. 2015 was €35.5 Mil.
Hence, Thoratec's Days Inventory for the
three
months ended in Jun. 2015 was 158.18.
The historical rank and industry rank for Thoratec's Days Inventory or its related term are showing as below:
FRA:TL1'
s Days Inventory Range Over the Past 10 Years
Min: 93.67 Med: 161.22 Max: 193.77
Current: 149.92
During the past 13 years, Thoratec's highest Days Inventory was 193.77. The lowest was 93.67. And the median was 161.22.
FRA:TL1's Days Inventory is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 193.905
vs FRA:TL1: 149.92
Thoratec's Days Inventory
declined
from Jun. 2014 (167.12) to Jun. 2015 (158.18).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Thoratec's Inventory Turnover for the
three
months ended in Jun. 2015 was 0.58.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Thoratec's Inventory-to-Revenue for the
three
months ended in Jun. 2015 was 0.54.
Thoratec Days Inventory Historical Data
The historical data trend for Thoratec's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Thoratec's Days Inventory
For the Medical Devices subindustry, Thoratec's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Thoratec's Days Inventory Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Thoratec's Days Inventory distribution charts can be found below:
* The bar in red indicates where Thoratec's Days Inventory falls into.
Thoratec Days Inventory Calculation
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Thoratec's Days Inventory for the fiscal year that ended in Dec. 2014 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thoratec (FRA:TL1) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Thoratec's Inventory Turnover for the
three
months ended in Jun. 2015 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Thoratec's Inventory to Revenue for the
three
months ended in Jun. 2015 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Thoratec Days Inventory Related Terms
Thank you for viewing the detailed overview of Thoratec's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.
Thoratec Corporation incorporated in the State of California in 1976 provides mechanical circulatory support with a product portfolio to treat the full range of clinical needs for advanced heart failure patients. It develops, manufactures and markets proprietary medical devices used for circulatory support. Following the sale of ITC in 2010, the Company has one operating segment: Cardiovascular group. This segment is organized and operates to develop and manufacture mechanical circulatory products to support the cardiovascular systems of humans. The Company's VAD products primarily serve patients suffering from late-stage HF. HF is a chronic disease that occurs when degeneration of the heart muscle reduces the pumping power of the heart, causing the heart to become too weak to pump blood at a level sufficient to meet the body's demands. Hospitals that perform open heart surgery and heart transplants are the potential customers for its Thoratec and HeartMate products. The Company estimates that it sells into 293 of these centers. According to the Company's estimates, it is in approximately 149 centers in the United States and 144 centers internationally. Competition from medical device companies and medical device divisions of healthcare companies, pharmaceutical companies and gene- and cell-based therapies is intense and is expected to increase. It therefore continues to expect new competitors both from the pharmacological and the medical device space. Among the medical device competitors are Aachen Innovative Solutions GmbH, AbioMed, Inc., Berlin Heart GmbH, HeartWare International Inc., Jarvik Heart, Inc., Maquet Cardiovascular, LLC (a division of Getinge AB), MicroMed Technology, Inc., Sun Medical Technology Research Corporation, SynCardia Systems, Inc., and Terumo Heart, Inc. All of the Company's proposed products will require regulatory approval prior to commercialization. In particular, medical devices are subject to rigorous pre-clinical testing as a condition of approval by the FDA and by similar authorities in foreign countries.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
FRA:TL1 has been successfully added to your 